Alternatives to Pentaomix

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Patool.AI uses hyperspectral imaging and deep learning for 'virtual staining' in tissue diagnostics.

Develops a computational model of the human body for drug discovery and development.

AI-powered platform for cancer diagnostics in digital pathology.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Developing CORA, a smart exam for early detection of coronary artery disease.

Developing advanced magnetic resonance imaging (MRI) technology for enhanced medical diagnostics.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

Develops toilet-integrated diagnostic technology for early health condition detection.

Developing novel diagnostics to predict patient response to immunotherapy.

AI-powered medical diagnostic support system for radiology and pathology.

Non-invasive device for real-time measurement of LVEDP and other vital hemodynamic indices.

ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.